top of page
Search
Reverse Split, Forward Motion: Shuttle Pharma Plans to Fuel Cancer Innovation by Shrinking Shares
Shuttle Pharmaceuticals (NASDAQ: SHPH) announced a critical strategic decision on Thursday.
Bristol Myers Squibb’s $40B U.S. Investment Signals a Strategic Bet on Domestic Manufacturing
As global pharmaceutical supply chains face renewed scrutiny and U.S. healthcare costs continue to climb, Bristol Myers Squibb (BMS) is making a bold and strategic move: a $40 billion investment in U.S.-based manufacturing over the next decade.
bottom of page